GSK (LON:GSK – Get Free Report)‘s stock had its “equal weight” rating restated by analysts at Barclays in a research note issued on Monday, MarketBeat.com reports. They presently have a GBX 1,450 ($18.28) price target on the stock. Barclays‘s price target indicates a potential upside of 5.52% from the stock’s previous close. Several other analysts […]